HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Gastroenterology

• Publication date

  1995-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0016-5085(95)90463-8PMID 7875491
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis.

  1994cited by this paper
• Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium.

  1994cited by this paper
• HLA‐DQB1 and ‐DQA1 typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours

  1993cited by this paper
• Nomenclature for factors of the HLA system, 1991.

  1992cited by this paper
• HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis.

  1992cited by this paper
• Amino acid substitutions at position 38 of the DRβ polypeptide confer susceptibility to and protection from primary sclerosing cholangitis

  1992cited by this paper
• Identification of the HLA-DRB1*04, -DRB1*07, and -DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours.

  1992cited by this paper
• HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours.

  1992cited by this paper
• HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation.

  1992cited by this paper
• Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system.

  1992cited by this paper
• Shared HLA class II-associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency.

  1992cited by this paper
• Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis.

  1992cited by this paper
• Inability to attribute susceptibility to primary sclerosing cholangitis to specific amino acid positions of the HLA-DRw52a allele.

  1991cited by this paper
• Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis

  1991cited by this paper
• Association of primary sclerosing cholangitis with HLA-DRw52a?

  1991cited by this paper
• Primary sclerosing cholangitis.

  1991cited by this paper
• Different amino acids at position 57 of the HLA-DQβ chain associated with susceptibility and resistance to IgA deficiency

  1990cited by this paper
• Association of primary sclerosing cholangitis with HLA-DRw52a.

  1990cited by this paper
• Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease.

  1989cited by this paper
• A DNA‐RFLP TYPING SYSTEM THAT POSITIVELY IDENTIFIES SEROLOGICALLY WELL‐DEFINED AND ILL‐DEFINED HLA‐DR AND DQ ALLELES, INCLUDING DRw10

  1988cited by this paper
• Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility.

  1988cited by this paper
• Identification and distribution of three serologically undetected alleles of HLA-DR by oligonucleotide.DNA typing analysis.

  1988cited by this paper
• HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus

  1987cited by this paper
• Enhanced autoreactivity of T‐lymphocytes in primary sclerosing cholangitis

  1987cited by this paper
• The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.

  1987cited by this paper
• HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology.

  1987cited by this paper
• HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus.

  1987cited by this paper
• HLA and Disease Associations

  1985cited by this paper
• The Data and Statistical Analysis

  1985cited by this paper
• Genetic markers in narcolepsy.

  1984cited by this paper
• HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive.

  1984cited by this paper
• HLA antigens in Japanese patients with narcolepsy

  1984cited by this paper
• HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease.

  1982cited by this paper
• Pathology of the Liver

  1981cited by this paper
• Long-standing asymptomatic primary sclerosing cholangitis report of three cases

  1981cited by this paper
• Clinicopathologic features of the syndrome of primary sclerosing cholangitis

  1980cited by this paper
• Clinicopathologic features of the syndrome of primary sclerosing cholangitis.

  1980cited by this paper
• High association of an HL-A antigen, W27, with ankylosing spondylitis.

  1973cited by this paper
• Ankylosing spondylitis and HL-A 27.

  1973cited by this paper
• An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area.

  1965cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE

  1955cited by this paper

• Hepatobiliary and pancreatic manifestations in inflammatory bowel disease: an umbrella review of meta-analyses

  2025cites this paper
• Primary Sclerosing Cholangitis

  2020cites this paper
• [Indications and follow-up for autologous hematopoietic stem cell transplantation in multiple sclerosis: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) in association with the Francophone Society of Multiple Sclerosis].

  2019cites this paper
• Extraintestinal manifestations of inflammatory bowel disease: Clinical aspects and pathogenesis.

  2018cites this paper
• Immunological Aspects of Gastrointestinal Diseases

  2017cites this paper
• T-cell receptors and human leukocyte antigens in primary sclerosing cholangitis

  2017cites this paper
• Pathogenesis and clinical spectrum of primary sclerosing cholangitis

  2017cites this paper
• The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood

  2016cites this paper
• Autoimmune liver diseases: internist's guide from bench to bedside

  2015cites this paper
• The major histocompatibility complex association in primary sclerosing cholangitis

  2015cites this paper
• Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.

  2015cites this paper
• Diagnosis and classification of primary sclerosing cholangitis.

  2014cites this paper
• Hepatobiliary manifestations of ulcerative colitis: an example of gut–liver crosstalk

  2014cites this paper
• Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.

  2013cites this paper
• Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.

  2013cites this paper
• A Case of Rapidly Progressive Primary Sclerosing Cholangitis Requiring Liver Transplantation

  2013cites this paper
• The spectrum of achalasia: lessons from studies of pathophysiology and high-resolution manometry.

  2013cites this paper
• Liver Disorders in Inflammatory Bowel Disease

  2012cites this paper
• Hepatobiliary disorders and complications of inflammatory bowel disease

  2011cites this paper
• Bile acids for primary sclerosing cholangitis.

  2011cites this paper
• Electrostatic modifications of the human leukocyte antigen DR P9 peptide‐binding pocket in primary sclerosing cholangitis: Back to the future with human leukocyte antigen DRβ

  2011cites this paper
• Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

  2011cites this paper
• Sclerosing Cholangitis and Recurrent Pyogenic Cholangitis

  2010cites this paper
• Glucocorticosteroids for primary sclerosing cholangitis.

  2010cites this paper
• Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease

  2010cites this paper
• Surveillance and Screening of Primary Sclerosing Cholangitis

  2009cites this paper
• HLA and Autoimmune Digestive Disease: A Clinically Oriented Review for Gastroenterologists

  2009cites this paper
• Current diagnosis and management of primary sclerosing cholangitis

  2008cites this paper
• [The current diagnosis of primary sclerosing cholangitis].

  2008cites this paper
• Primary sclerosing cholangitis.

  2008cites this paper
• Pregnancy in patients with primary sclerosing cholangitis.

  2008cites this paper
• Primary sclerosing cholangitis.

  2008cites this paper
• [Hepatobiliary manifestations in inflammatory bowel disease].

  2007cites this paper
• Immunogenetics of Autoimmune Liver Disease

  2007cites this paper
• Recurrence of primary sclerosing cholangitis after living donor liver transplantation

  2007cites this paper
• Hepatobiliary manifestations of inflammatory bowel disease

  2007cites this paper
• Human leukocyte antigen associations in Finnish liver transplantations due to primary sclerosing cholangitis and primary biliary cirrhosis

  2007influential citation
• Hepatobiliary dysfunction in patients with inflammatory bowel disease

  2006cites this paper
• Basic concepts in primary sclerosing cholangitis: what can we learn from studies of its genetic basis

  2005cites this paper
• Increased prevalence of primary sclerosing cholangitis among first-degree relatives.

  2005cites this paper
• Primary sclerosing cholangitis in two brothers: report of a family with special emphasis on molecular HLA and MICA genotyping.

  2005cites this paper
• Characterization, Outcome, and Prognosis in 273 Patients with Primary Sclerosing Cholangitis: A Single Center Study

  2005cites this paper
• Immunopathogenesis of primary sclerosing cholangitis

  2005cites this paper
• Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1.

  2004cites this paper
• Glucocorticosteroids for primary sclerosing cholangitis.

  2004cites this paper
• Primary sclerosing cholangitis.

  2004cites this paper
• 38 Hepatobiliary disorders

  2003cites this paper
• Bile acids for primary sclerosing cholangitis.

  2003cites this paper
• Primary sclerosing cholangitis.

  2003cites this paper
• Epidemiology of autoimmune liver disease

  2003cites this paper
• Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population.

  2003cites this paper
• Hepatic manifestations of gastrointestinal diseases. Inflammatory bowel disease, celiac disease, and Whipple's disease.

  2002cites this paper
• Autoantibodies Directed Against Ribosomal Proteins in Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Comparative Study

  2002cites this paper
• for hepatocellular carcinoma in liver cirrhosis: have programmes improved because patients have?

  2002cites this paper
• Hepatobiliary disease in inflammatory bowel disease.

  2002cites this paper
• New steroids for IBD: progress report

  2002cites this paper
• Evaluation of the Role of MHC Class II Alleles, Haplotypes and Selected Amino Acid Sequences in Primary Sclerosing Cholangitis

  2002cites this paper
• Primary sclerosing cholangitis is associated to an extended B8‐DR3 haplotype including particular MICA and MICB alleles

  2001cites this paper
• Association of HLA-DR genes with mild idiopathic adulthood biliary ductopenia

  2001cites this paper
• Primary sclerosing cholangitis associated with rheumatoid arthritis and HLA DR4: is the association a marker of patients with progressive liver disease?

  2001cites this paper
• Primary sclerosing cholangitis

  2001cites this paper
• Immunogenetics in PSC.

  2001cites this paper
• The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis.

  2001cites this paper
• Association of the tumour necrosis factor á − 308 but not the interleukin 10 − 627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis

  2001cites this paper
• Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism.

  2001cites this paper
• Aetiopathogenesis of primary sclerosing cholangitis.

  2001cites this paper
• Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16‐year prospective study

  2001cites this paper
• The HLA-DR3,DQ2 Heterozygous Genotype is Associated with an Accelerated Progression of Primary Sclerosing Cholangitis

  2001influential citation
• Association of the tumour necrosis factor α −308 but not the interleukin 10 −627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis

  2001cites this paper
• Primary sclerosing cholangitis as an autoimmune disease: pros and cons

  2000cites this paper
• Is there a cirrhotic cardiomyopathy?

  2000cites this paper
• Primar sklerosierende Cholangitis

  2000cites this paper
• HLA and Gastrointestinal Diseases

  2000cites this paper
• Genetics of autoimmune liver disease

  2000cites this paper
• Bile duct bacterial isolates in primary sclerosing cholangitis and certain other forms of cholestasis--a study of bile cultures from ERCP.

  2000cites this paper
• Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis

  2000cites this paper
• Identification of Helicobacter pylori and OtherHelicobacter Species by PCR, Hybridization, and Partial DNA Sequencing in Human Liver Samples from Patients with Primary Sclerosing Cholangitis or Primary Biliary Cirrhosis

  2000cites this paper
• Defining the relationship between autoimmune disease and primary sclerosing cholangitis

  2000cites this paper
• Gut-liver axis

  2000cites this paper
• Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis

  2000cites this paper
• The interleukin-1 and interleukin-10 gene polymorphisms in primary sclerosing cholangitis: no associations with disease susceptibility/resistance.

  2000cites this paper
• Advances in Abdominal Surgery

  1999cites this paper
• Definition and pathology of primary sclerosing cholangitis.

  1999cites this paper
• Pathogenesis and medical therapy of primary sclerosing cholangitis. Any news?

  1999cites this paper
• Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis.

  1999cites this paper
• National survey of primary sclerosing cholangitis: an emergent indication for new therapeutic strategies

  1999cites this paper
• HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations.

  1999cites this paper
• Colangitis esclerosante primaria

  1999cites this paper
• Hepatobiliary manifestations of inflammatory bowel disease.

  1999cites this paper
• Diagnosis of primary sclerosing cholangitis.

  1999cites this paper
• Primary sclerosing cholangitis in children

  1999cites this paper
• Etiology and natural history of primary sclerosing cholangitis.

  1999cites this paper
• Primary biliary cirrhosis and primary sclerosing cholangitis.

  1999cites this paper
• Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers.

  1998cites this paper
• Cytokine production from colonic T cells in patients with ulcerative colitis with and without primary sclerosing cholangitis

  1998cites this paper
• Human leukocyte antigen‐C genes and susceptibility to primary sclerosing cholangitis

  1998cites this paper
• Frequent occurrence of non-specific gliadin antibodies in chronic liver disease. Endomysial but not gliadin antibodies predict coeliac disease in patients with chronic liver disease.

  1997cites this paper
• Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis.

  1997cites this paper
• Preferential Vβ3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis

  1997cites this paper
• Predisposing factors in sulphasalazine-induced systemic lupus erythematosus.

  1997cites this paper